Despite great innovation over the last year, the need to solidify digital transformation and continually adapt to the changing needs of healthcare providers and patients means much uncertainty remains around how to deliver a digital and patient-first future, ensuring long-term customer value and life-changing treatments.
It's why we're excited in 2021 to launch a new product offering built for the virtual age. We aim to provide you with the insights and answers to the array of new challenges and opportunities today's world presents to pharma. Newly launched Reuters Professional Access delivers unbiased and industry-leading insights that fuel the decisions of tomorrow.
- Confidence in decision making – hear from pharma industry leaders and disruptive innovators such as David Fredrickson, EVP Oncology Business Unit, Astrazeneca; Kabir Nath, President and CEO, Otsuka North America; Vicky DiBiaso, Global Head Patient Informed Development & Health Value Translation, Sanofi; Cindy Hoots, Chief Digital Officer & CIO, Astrazeneca and more, navigating their businesses through unprecedented change
- Unique industry insights and case studies – hear from leading pharma companies including GSK, Astrazeneca, Sanofi, Eli Lilly, Pfizer, BMS, Bayer and more - understand steps they have taken, results they have seen, and where they will position themselves in the long-term
- Accelerate change – immediate access to game changing information with tactical and practical takeaways that can be immediately implemented
- Access to an expansive network of industry peers – at a time when we can’t meet in person, build relationships with individuals facing the same issues as you or solving your challenges
- Accelerate your career – master your role at a turbulent time and get ahead on your personal development
SVP Marketing, Novo Nordisk
Reuters Events is strategically & operationally valuable for staying at the forefront of the pharma industry evolution.
